Kingworld Medicines Group Limited (1110.HK) Stock
Kingworld Medicines Group Limited functions as an investment holding company primarily engaged in the distribution of imported, branded pharmaceutical and healthcare items. The company also supplies a range of medical products, health goods, and general food items.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Peer Comparison
About Kingworld Medicines Group Limited
Kingworld Medicines Group Limited functions as an investment holding company primarily engaged in the distribution of imported, branded pharmaceutical and healthcare items. The company also supplies a range of medical products, health goods, and general food items. Its extensive product catalog caters to various therapeutic areas, such as respiratory relief (for cough and phlegm), gastrointestinal issues, vitamin supplementation, orthopedic support, cardiovascular health, and influenza care. Key brands distributed include Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, the Kawai Product Range, Flying Eagle Wood Lok Medicated Oil, Kyushin Pill, and the Mentholatum Product Range. Furthermore, Kingworld is involved in the production and sale of electrotherapeutic and physiotherapeutic devices, as well as common medical examination equipment. Its market presence spans the People's Republic of China, Hong Kong, the United States, the United Kingdom, Germany, Italy, Spain, Mexico, and other international regions. The company, founded in 1996, is headquartered in Shenzhen, PRC.
Kingworld Medicines Group Limited is led by CEO Li Sheng Zhao, employs 732 people, headquartered in Shenzhen, CN, publicly traded since 2010.
over the past 52 weeks the stock has ranged between $0.33 and $0.78, and currently trades 38.5% below its 52-week high.
Official website: www.kingworld.com.cn